tomeko

Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia

Just diagnosed with Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, look for clinical trials, and connect with others living with it — all in one place.

Open the full Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia hub →

Overview

Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia is a rare condition. Also known as AOA1. Tomeko brings together the specialists, research, clinical trials, treatments and community for Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:1168 · OMIM 208920 · ICD-10 G11.3 · GARD 0009283

Find care for Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia

Authoritative references for Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia

Common questions

I was just diagnosed with Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, filtered to your area.

Are there clinical trials for Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia?

Tomeko shows live, recruiting studies for Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com